On December 30, 2022, Kangbaier ushered in a historic shining moment and successfully listed on the OTC market in the United States！The enterprise has achieved gratifying results! The enterprise ushered in a new starting point, but also entered a new journey.

On February 8, 2023, Liaoning Kangbaier Biotechnology Development Co., Ltd. officially held a listing ceremony in Panjin City to celebrate the success of Kangbaier’s listing in the American Capital Market, and clearly defined the next stage of the board-landing on the main board of the NASDAQ market.

In order to further understand the requirements of the NASDAQ board transfer in the United States, as well as the clear transfer work plan, on March 22, 2023, America General Business Association (AGBA) & SME Overseas IPO Capital Group team members visited Panjin City, and held the launch conference of the NASDAQ board transfer together with Kangbaier Group, and explain to the company's senior management team and market management members about the specific program content of Kangbaier board.

After the launch conference was held, the strategic planning and marketing strategy of Kangbaier were successfully implemented, and the marketing team achieved excellent results, laying a solid foundation for the upgrade of Kangbaier. On October 20, 2023, Kangbaier held a briefing on the work of the board transfer. The information publicity officer of America General Business Association (AGBA) & SME Overseas IPO Capital Group explained the specific work arrangements and the current work progress of Kangbaier's board transfer. Mr. Alan from Hong Kong, general financial consultant of Kangbaier Listing, also attended the meeting, and connected with American lawyers at the meeting site, and translated the description of Kangbaier's work in the recent stage reported by American lawyers for everyone. In order to plan the next step of Kangbaier's board work strategy, the Kangbaier listing report was held on January 27, 2024.

Evelyn, Information and publicity Officer of America General Business Association (AGBA) & SME Overseas IPO Capital Group shared the recent overview of the US capital market environment, the trend of China Concept Stock go public in the US and the trading performance of the NASDAQ Main Board at the Kangbaier listing conference and brand launch and stressed the key work arrangements of Kangbaier in the future.

At present, Kangbaier has been listed on the OTC for one year and will make full preparations to achieve the goal of switching to the board in 2024. In accordance with SOX, Kangbaier has developed and implemented internal control compliance system and improved the corporate governance structure; continuously employ domestic and foreign lawyers, accountants and auditors to ensure the relevant tripartite reports required by Kangbaier before listing and the disclosure of major relevant information of the company. At the same time, Kangbaier has been continuously and deeply optimizing the corporate strategic layout, brand influence and business model, in order to meet the mandatory requirements of net profit and market value. We believe that under the professional guidance of the listing advisory team and the close cooperation and promotion of Kangbaier, we will complete the preparatory work before the board transfer as soon as possible.

Qingyimei brand conference & BDS Roast opening ribbon cutting site

Kangbaier turning to NASDAQ is moving because of the trend, riding the trend, but also the trend in the win! I wish every partner of Kangbaier can make concerted efforts and work together under the leadership of Chairman Sun to successfully land in the main board market of NASDAQ in the future harvest season, full of success! For the listing of the road to hand in a perfect answer!